Chemoinformaics analysis of CHRYSOPHANIC ACID-9-ANTHRONE
| Molecular Weight | 240.258 | nRot | 0 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 16 |
| Exact Molecular Weight | 240.079 | nRing | 3 |
| Solubility: LogS | -3.443 | nHRing | 0 |
| Solubility: LogP | 4.284 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 35.4575 |
| nHD | 2 | BPOL | 12.9065 |
| QED | 0.528 |
| Synth | 2.368 |
| Natural Product Likeliness | 1.006 |
| NR-PPAR-gamma | 0.982 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.003 |
| HIA | 0.048 |
| CACO-2 | -4.988 |
| MDCK | 0.0000114 |
| BBB | 0.024 |
| PPB | 0.988262 |
| VDSS | 0.565 |
| FU | 0.0201619 |
| CYP1A2-inh | 0.988 |
| CYP1A2-sub | 0.692 |
| CYP2c19-inh | 0.392 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.683 |
| CYP2c9-sub | 0.82 |
| CYP2d6-inh | 0.746 |
| CYP2d6-sub | 0.57 |
| CYP3a4-inh | 0.179 |
| CYP3a4-sub | 0.119 |
| CL | 9.19 |
| T12 | 0.771 |
| hERG | 0.017 |
| Ames | 0.761 |
| ROA | 0.555 |
| SkinSen | 0.954 |
| Carcinogencity | 0.716 |
| EI | 0.965 |
| Respiratory | 0.771 |
| NR-Aromatase | 0.044 |
| Antiviral | Yes |
| Prediction | 0.660635 |